In Vitro Diagnostics - Research and Markets - RSS Feed

Innovations in In-Vitro Diagnostics - New Technologies, Growth Opportunities, and the Future Market Outlook

press@researchandmarkets.com — Thu, 16 Jul 2009 09:38:20 GMT

Clinical diagnostics is an attractive and growing industry, with the majority of major diagnostic companies experiencing sales growth of over 10% in 2008, despite significant pricing pressures However, achieving market growth is becoming increasingly challenging due to the difficulty in developing...

The Top 40 Manufacturers In Europe Of In Vitro Diagnostics For Infectious Diseases

press@researchandmarkets.com — Mon, 04 May 2009 20:42:01 GMT

According to The European Society of Clinical Microbiology and Infectious Diseases (ESCMID), infectious diseases are a public health priority for Europe ESCMID has identified AIDS, tuberculosis, healthcare associated infections and epidemic infections as major threats to Europe As, The Top 40...

The Top 20 Manufacturers In Europe Of Clinical Chemistry Analyzers & Reagents

press@researchandmarkets.com — Mon, 04 May 2009 20:28:46 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year It is estimated that clinical chemistry testing accounts for 34 5% of...

The Top 60 Manufacturers Worldwide Of IVD For Infectious Diseases

press@researchandmarkets.com — Mon, 04 May 2009 20:20:51 GMT

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another As The Top 60 Manufacturers Worldwide Of In Vitro Diagnostics For Infectious Diseases is published, the current...

The Top 30 Manufacturers In Europe Of IVD For Haematology & Coagulation Testing

press@researchandmarkets.com — Mon, 04 May 2009 20:14:00 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year It is estimated that haematology and coagulation testing accounts for...

The Top 20 Manufacturers Of In Vitro Diagnostics In France, Belgium & The Netherlands

press@researchandmarkets.com — Mon, 04 May 2009 20:07:07 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year Within the region, France, Belgium & The Netherlands had sales of...

The Top 20 In Vitro Diagnostics Manufacturing Companies In The United Kingdom & Ireland

press@researchandmarkets.com — Mon, 04 May 2009 19:57:50 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year Within the region, the United Kingdom & Ireland had sales of €826...

The Top 30 In Vitro Diagnostics Manufacturing Companies In Germany

press@researchandmarkets.com — Mon, 04 May 2009 19:51:07 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year Within the region, Germany had the biggest market share with sales of...

The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe (2nd ed.)

press@researchandmarkets.com — Thu, 30 Apr 2009 21:43:37 GMT

According to figures published in December 2008, by the European Diagnostic Manufacturers Association, European sales of in vitro diagnostics reached €9,685 million in 2007 This represented an increase of 4% over the previous year Within the region, Germany had the biggest market share with sales of...

2009 U.S. In-Vitro Diagnostic Substance Manufacturing Industry Report

press@researchandmarkets.com — Thu, 16 Apr 2009 11:24:14 GMT

The U.S. In-Vitro Diagnostic Substance Manufacturing Industry report, published annually, contains timely and accurate industry statistics, forecasts and demographics. The report features 2009 current and 2010 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. The report also includes industry definition, 5-year historical trends on industry sales, establishments and employment, a breakdown of establishments, sales and employment by employee size of establishment (9 categories), and estimates on up to 10 sub-industries, including enzyme and isoenzyme diagnostic agents, blood derivative diagnostic agents, and pregnancy test kits.

Industry Definition and Related Industries

NAICS 325413: In-Vitro Diagnostic Substance Mfg.

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

Related Industries
- Medical Laboratories
- Medical & Surgical Hospitals
- Emergency Centers
- Kidney Dialysis Centers

NAICS 325413: In-Vitro Diagnostic Substance Mfg. is
85% of SIC 2835Diagnostic substances

Sub-Industries
- Diagnostic substances
- Barium diagnostic agents
- Blood derivative diagnostic agents
- Cytology and histology diagnostic agents
- Electrolyte diagnostic agents
- Enzyme and isoenzyme diagnostic agents
- Hemotology diagnostic agents
- In vitro diagnostics
- In vivo diagnostics
- Microbiology and virology diagnostic products
- Pregnancy test kits
- Radioactive diagnostic substances
- Veterinary diagnostic substances

The Top Ten Global In-Vitro Diagnostics Companies: Positioning, Performance and SWOT Analyses

press@researchandmarkets.com — Fri, 03 Apr 2009 09:45:52 GMT

The in-vitro diagnostics (IVD) market continues to grow at a steady pace, driven by new fields such as molecular diagnostics and a growing consumer awareness surrounding disease management There is also an increasing focus on emerging markets, where healthcare infrastructures are improving The...

Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

press@researchandmarkets.com — Wed, 11 Mar 2009 10:31:27 GMT

Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for in-depth information and data relating to the Australia In vitro diagnostic devices market It also offers detailed and comprehensive coverage of market revenue,...

Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

press@researchandmarkets.com — Wed, 11 Mar 2009 10:31:26 GMT

Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Japan In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Japan

Scope

-The report provides in vitro diagnostics information broken down into detailed categories and segments in Japan.
-Total revenues, end users
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the in vitro diagnostics devices market in Japan.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identify an

Spain In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

press@researchandmarkets.com — Wed, 11 Mar 2009 10:31:26 GMT

Spain In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Spain In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Spain

Scope

-The report provides in vitro diagnostics information broken down into detailed categories and segments in Spain.
-Total revenues, end users
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the in vitro diagnostics devices market in Spain.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identify an

France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

press@researchandmarkets.com — Wed, 11 Mar 2009 10:31:26 GMT

France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the France In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in France

Scope

-The report provides in vitro diagnostics information broken down into detailed categories and segments in France.
-Total revenues, end users
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the in vitro diagnostics devices market in France.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identi

Global In Vitro Diagnostics (IVD) Market: An Analysis

press@researchandmarkets.com — Tue, 20 Jan 2009 10:26:42 GMT

The global In Vitro Diagnostic (IVD) industry is witnessing a period of profound growth The growth is coming from different regions and markets The various sub-segments of IVD are also giving the industry a big push The increase in the aging population is also driving the demand of IVD devices world...

North American Medical Ultrasound Imaging Markets

press@researchandmarkets.com — Fri, 09 Jan 2009 12:28:57 GMT

This research study analyzes the North American medical ultrasound imaging market from 2005 to 2015 with a base year of 2008 The main chapters of the research service include an executive summary, overview of the market segments for new and remarketed ultrasound imaging equipment, ultrasound...

Three Alternative Scenarios of the Future In Vitro Diagnostics Market 2009-2018

press@researchandmarkets.com — Wed, 13 Aug 2008 07:42:05 GMT

This report is an invaluable strategic planning resources for corporate, marketing and R&D executives This report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead Scenario I: Business-As-Usual Scenario II: Economic Austerity Scenario III:...

Global In Vitro Diagnostic Market Analysis

press@researchandmarkets.com — Mon, 26 May 2008 11:49:01 GMT

The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient awareness, continue to fuel growth in global...

In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its Foreign Trade

press@researchandmarkets.com — Tue, 22 Apr 2008 14:26:43 GMT

The In-Vitro Diagnostic Substance Manufacturing Industry report provides in-depth analysis of the industrys key financial data, cost and pricing, competitive landscape, industry structure, and trends and opportunities.

Find in this new report complete 2007 data and outlook into year 2012 for the industry represented by the 6-digit NAICS code 325413. This 162-page report also includes the most recent information on the global market and overseas growth opportunities. This detailed information resource contains at least 5 years of independently researched industry statistics cross-referenced with the relevant U.S. and international economic indicators. All data have been verified to ensure the highest quality.

In this report, you will find industry data on the following major categories:

Executive Summary

Quick Industry Statistics: 2-page overview for the CEO on the run

Supply & Demand with Capacity Utilization

2012 Outlook domestic and international

Industry Income Statement

All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.

4-year Financials Comparison and Trends

Industry Balance Sheet

Traditional key elements of Assets, Liabilities, and Equity

Inventory fabrication stages

Calculated balance sheet ratios

Capital Expenditure

Plant additions and expansions

Computer and IT investments

Machinery and Equipment for production and material handling

Industry Cost Analysis

Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight

Materials and their percentage share of total material costs

Industry Pricing Analysis

Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting

Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

Industry Foreign Trade

Detailed Import/Export Data by commodities and by

In Vitro Diagnostics: Development Through Postmarket

press@researchandmarkets.com — Fri, 04 Apr 2008 15:37:51 GMT

Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales To achieve commercial success, in vitro diagnostic (IVD) companies must earn the approval of several different groups Regulators, payer organizations, healthcare...

In Vitro Diagnostics Market Profile: Detailed Analysis of the Medical Equipment Market Covering Medical Devices, Biomedical Devices, Healthcare Appliances and Medical Supplies.

press@researchandmarkets.com — Fri, 19 Oct 2007 16:07:10 GMT

In Vitro Diagnostics Market Profile

- This report is an essential source for key information and data relating to the In Vitro Diagnostics market. The report provides overview of key trends, drivers and restraints, future outlook, competitive landscape and key developments in the In Vitro Diagnostics market. It also offers global, regional and country level, detailed and comprehensive coverage of market revenue, volume, distribution and company share information.

Report Coverage

- Detailed global, regional (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa) and country level (United States, Germany, United Kingdom, France, Italy, Spain, and Japan) data on market size by volume and value for the sub-segments in the In Vitro Diagnostics market.
- Insightful company share information for leading competitors, revenues by distribution channel and forecasts of market values for the sub-segments at global, regional and country level.
- Analysis of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.
- All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Why Buy?

- Obtain the most up to date the In Vitro Diagnostics market information available.
- Support business/sales activities by understanding your customers’ businesses better.
- Identify key growth market categories and segments.
- Analyze the latest market information and trends.
- Develop your strategies on the basis of forecast market growth.

In Vitro Diagnostic Companies Analysis

press@researchandmarkets.com — Wed, 10 Oct 2007 15:23:20 GMT

This new report from provides an evaluation of the products, alliances and performance of over 30 leading global players Evaluation of the products, alliances and performance of over 30 leading global players HUGE POTENTIAL The global market for in vitro diagnostics (IVD) in 2007 is estimated to be...

Strategic Alliances in the Global IVD Markets

press@researchandmarkets.com — Wed, 03 Oct 2007 16:19:04 GMT

This Frost & Sullivan research service titled Strategic Alliances in the Global IVD Market provides an overview of the strategic alliances taking place in this market and offers strategic solutions to manufacturers to gain advantage in this growing market Technologies The following technologies are...

Major Presence in In Vitro Diagnostics Markets

press@researchandmarkets.com — Fri, 12 Jan 2007 16:39:53 GMT

This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets.

A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology.

Strategic Analysis of the European In Vitro Cancer Diagnostics Market

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:54 GMT

Collaborations between Emerging and Leading In-vitro Cancer Diagnostics Companies Vital for Greater Market Penetration

With cancer-related deaths in Europe touching one million, there has been a substantial rise in the consumption of resources for diagnosis, treatment and care. Throughout Europe, the five-year survival rate of cancer patients is a mere 30 per cent to 60 per cent. However, in recent times, there has been a reduction in the mortality rate by 10 per cent, which is a gain of 92,000 lives. In this scenario, the in-vitro cancer diagnostics industry is expected to play a vital role in tackling this disease, with encouragement from the collaboration between emerging diagnostic companies and leading participants. Collaborations help the smaller participants with invaluable intellectual property rights, market their tests better.

This Frost & Sullivan research service provides an overview of and outlook for the European in-vitro cancer diagnostics market. The research provides detailed revenue forecasts by end user to help design marketing strategies and maximise growth. The study looks at the vast potential the market holds on account of the range of potential therapeutic approaches available to treat cancer. This enables companies to align their positioning strategies to benefit from the changing markets and obtain maximum return on investments.

Ageing Population Increase Incidence of Cancer, Driving Demand for In-vitro Diagnostics

The European population is slowly ageing, with 17 per cent of the population in almost all the countries being aged 65 years and above. This swelling population segment coupled with the largely unhealthy lifestyle of the Europeans is likely to double the current number of cancer-related cases by 2020, creating robust demand for in-vitro diagnostics. Moreover, the varying survival rates in different European nations strongly indicate that market participants are likely to find immense opportunities in the countries with low

World In Vitro Diagnostic Technologies Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:28 GMT

Advanced Technologies Heighten Testing Efficiency

In vitro diagnostics (IVD) is a valuable testing technology utilized to facilitate
medical diagnosis and monitor treatment efficacy. The results of such
laboratory tests are extremely influential in determining a physician’s course
of treatment when various options are available. More importantly, IVD allows
for early and accurate diagnosis of a disease, resulting in more
efficient treatment.

This Frost & Sullivan study offers an in-depth analysis of the world in vitro
diagnostic technologies markets. By identifying industry challenges and
examining the competitive market structure, this research provides your firm
with a comprehensive guide to maximize its profitability.

Consumer Education Drives Demand for Alternative Testing Methods

As individuals become more knowledgeable about healthcare topics, largely
due to the popularity of the Internet, patients are increasingly questioning
physicians about testing options and protocols. Within the past several years,
patients have begun to adopt a more proactive role in their own well-being.
As medical news and issues permeate the minds of people, they will begin to
evaluate their own needs and seek further, specific information from their
physicians. Consequently, doctors will recognize the benefits of newer
technologies and implore facilities to update their laboratories, states the
author of this research.

Sluggish Return on Investment Stagnates Innovative Technology Purchases

Laboratory capital investments are often expected to produce returns over at
least a decade. As a result, product and instrument replacement cycles are
often long and impede the introduction of new technology.

Laboratories want to ensure returns on their investments and then some,
says the author. This is a circuitous, historic problem. End users want the best
price for an up-to-date product that will last a long time. However, with
technology advances as dynamic as they are, n

In-vitro Diagnostics--Industry Impact (Technical Insights)

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:27 GMT

Significant Product Benefits to Break Down Customer Reluctance toward Adopting New Assays
End-user skepticism regarding the reliability of new assays for in-vitro diagnostics can be remedied with effective demonstrations and customer education about their remarkable benefits. Companies need to train lab personnel on the use of these new tests as well as educate physicians about the ability of these tests to improve the overall cost efficiency and patient outcomes. These assays allow accurate and early diagnosis of life-threatening diseases along with continuous patient monitoring. The evidence of their success is the wider acceptance of newly developed tumor and prostrate markers, breast cancer tests, and assay technologies known for higher sensitivity and specificity, fast turn-around times, easy-to-use interfaces, and low cross reactivity.
This Technical Insights study examines the impact of in-vitro diagnostics on the healthcare market. It offers an analysis of recent developments in the in-vitro diagnostics industry and identifies commercial applications. This research service enables companies to align their positioning strategies to benefit from these technologies.

Molecular Diagnostic Assays Show Immense Promise
Molecular diagnostics is the most promising area of growth in the in-vitro diagnostics space, since it is now used to cure several infectious diseases. Companies are focusing on developing new assays in the human immunodeficiency virus/hepatitis C virus (HIV/HCV) area using innovative technologies, says the analyst of this research service. The healthcare industry is also witnessing a shift toward personalized medicine and gene-based detection tests, especially for cancer.
The platform for diagnosable diseases has broadened with scientists developing molecular diagnostic assays for diseases such as cancer, AIDS, influenza, and Alzheimer's. The continuous discovery of new gene targets has further helped in expanding the base of curable diseases.

Global In Vitro Diagnostic Market Outlook

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:27 GMT

Global Cost Containment Efforts and Economic Constraints Limit Growth of Market
While the In Vitro Diagnostics (IVD) segment represents only 2-3% of total healthcare expenses, it is still greatly affected by global healthcare cost containment efforts. These efforts have been and will continue constraining market growth. In developing countries, particularly those in Asia, Latin America, and Africa, poor healthcare infrastructures and struggling economies have greatly impeded modernization resulting in price sensitive environments. Fortunately, healthcare awareness programs and government initiatives to increase spending are stimulating improvements in medical care and broadening healthcare coverage in these countries. This is opening up major opportunities for future growth. As a result, understanding individual markets and clinical needs is imperative to overcoming obstacles and promoting the adoption of new technologies. Manufacturers are currently focusing on consolidation and maintaining low prices, and keep in mind that new systems must address significant unmet needs and provide substantial added value.
This Frost & Sullivan research service evaluates current and future trends in the global IVD market. It identifies key drivers and restraints, and provides strategic recommendations for overcoming challenges and maximizing opportunities. This study focuses on 16 leading country markets as well as 10 segments of the IVD industry.

New Technology Creates Opportunities for Growth in IVD Markets
There currently exists great market potential for IVDs, especially considering that they account for a small percentage of total healthcare costs. In particular, the development of molecular diagnostic assays used to test newly identified disease targets is fueling excitement over the promise of personalized medicine and theranostics.
Additionally, demand for nearer to patient testing is driving major growth in point of care (POC) systems. Successfully igniting growth wi

Strategic Analysis of the European In Vitro Diagnostics Market

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:27 GMT

Laboratory Testing Still Regarded as a Cost Centre

In vitro diagnostics (IVD) have traditionally been offered a raw deal by the medical fraternity who considered it inconsequential to long-term or direct treatment - a mere addition to existing costs. Hence, suppliers need to take the initiative to demonstrate the cost benefits of IVDs and its undeniable role in optimising patient management. In fact, several case studies, involving therapeutic drug monitoring, have already shown that test-driven medications result in huge financial and therapeutic benefits. Fortunately, healthcare providers are realising that IVD testing goes beyond diagnostics and is likely to play a key role in the actual treatment of the disease. Essentially, IVDs identify symptoms much quicker, monitor treatment throughout the progression of the disease and improve decision-making considerably with the net result of relieving the burden on healthcare systems.

This Frost & Sullivan research evaluates the current and future trends in the European IVD market. It analyses key drivers and restraints that influence the market and also provides strategic recommendations to overcome the challenges and exploit emerging opportunities. The study highlights developments in key market segments that include clinical chemistry, coagulation, haematology, immunoassay, microbiology, molecular biology and point-of-care testing (POCT).

IVD Testing in Primary Care Settings - Possibility in the Future

Ironically, while IVD tests remain centralised and restricted to laboratories, up to 90 per cent of the patients in the United Kingdom are receiving treatment in primary care. However, things are likely to change in the future with the movement of diagnostics from laboratories closer to the patient. Also known as POCT, this trend is likely to push IVD into primary care settings. As patients are moved around within a healthcare system, their information should be instantly accessible, explains the analyst. The

Strategic Analysis of the In Vitro Diagnostics (IVD) Markets in Asia

press@researchandmarkets.com — Tue, 09 Jan 2007 11:17:26 GMT

Emerging Asian Economies Provide Growth Opportunities to IVD Market Participants

In vitro diagnostics (IVD) is one of the most exciting segments in global healthcare and the Asian IVD markets have been expanding at a double-digit rate. This growth is propelled by increased affluence, awareness, and spending on healthcare in this region. While the swelling Asian economies continue to fuel demand for IVD, participants in this market must overcome challenges related to distribution channels, intellectual property protection, and a strong local industry to achieve optimum market development.

Frost & Sullivan’s recent strategic analysis of the Asian IVD market offers in-depth information about the total Asian market along with an overview of the clinical chemistry, microbiology, hematology, point of care (POC), coagulation, molecular biology, and immunoassay segments.

Ageing Population and Mounting Government Measures Stimulate Market Growth

Asian governments are under increased pressure to provide elderly populations - which are expected to double in the near future - with adequate healthcare. The desire of the ageing population to remain healthy and active is a leading market driver, says the analyst of this research. For instance, with over 20 percent of the Japanese population above the age of 65 and a decreasing productive population:elderly population ratio, the Japanese government is under tremendous pressure to reduce costs for healthcare facilities.

Governments are also imposing stricter disease control measures, motivating market growth and demand, as well as creating a positive impact on the IVD market. The move toward integrated healthcare, especially with the consistent shift toward ‘proactive’ testing rather ‘reactive’ testing, is also expected to propel IVD markets.

Rising Demand for High Quality Healthcare

As Asian economies grow, their populations with increased average life expectancies have also been rising.

Sector Snapshot: In Vitro Diagnostic Industry Leading Players Comparison and Review

press@researchandmarkets.com — Mon, 08 Jan 2007 12:54:27 GMT

This “Sector Snapshot” is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot details the top 15 in-vitro diagnostic (IVD) companies who continue to dominate the steadily growing IVD space. They are Roche Diagnostics, Abbott Laboratories, Bayer Diagnostics, Becton, Dickinson and Co., Beckman Coulter, Dade Behring, Ortho-Clinical Diagnostics, bioMérieux, Sysmex, Bio-Rad, Arkray, Diagnostic Products, Olympus America, Cytyc and Gen-Probe.

Sector Snapshot: Chinas In Vitro Diagnostic Testing Industry

press@researchandmarkets.com — Tue, 19 Dec 2006 10:40:24 GMT

This “Sector Snapshot” is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends This sector snapshot details the Chinese in vitro diagnostic (IVD) markets, Chinese clinical hematology market and IVD market dynamics This...

In Vitro Diagnostics Deals: Therapeutic Area Trends

press@researchandmarkets.com — Fri, 15 Dec 2006 11:54:36 GMT

IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: an estimated 60-70% of medical decisions involve a diagnostic test This report focuses on IVD industry deals of the last few years and what they reveal about the current strategies of some of the industry’s...

World Protein Arrays Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:51 GMT

High Inter-array Reproducibility Necessary to Drive Further Research in Protein Arrays

Research programs using protein arrays have been hampered by low inter-array reproducibility. Easy-to-use technologies that enable high throughput at an increased level of reproducibility are in great demand. Further technological developments are needed to enable researchers to benefit fully from protein arrays.

This research examines the world protein arrays markets and focuses on the technologies currently available and those poised to enter the market. The study offers revenue forecasts by market segments and covers key drivers and restraints affecting market growth. It also provides recommendations to overcome market challenges.

Automation Enhances Increased Protein Array Sample Throughput

The trend of continuous automation of the drug discovery market is carrying over to the protein array market, aiding researchers to reduce the occurrence of manual errors. Current technological advances are clearing the way for protein arrays to become regular fixtures in research, facilitating frequent experiments, states the analyst.

Increasing Availability and Validity of Content Drives Demand and Growth

The demand for increased availability of validated content for protein arrays is expected to escalate as the research market continues to progress. However, the quantity of validated content currently available does not meet researchers requirements. This creates a challenge for researchers in meeting their research goals at an accelerated pace, notes the analyst. Companies providing high-quality validated content are likely to experience increased market growth.

North American, Latin American, and Asian PACS Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:46 GMT

High Speed Digital Transmission Benefits Drive PACS Adoptions

Picture archiving and communications systems (PACS) store, retrieve,
transmit, and display medical images in digital format. With the advent of
networked facilities, it has become possible to design distributed archives

where PACS data can be stored at various locations yet still be quickly

accessible. Though these systems are costly, the benefits in operational
efficiency and cost-effectiveness have spurred healthcare facilities to
implement a phased adoption strategy.

This Frost & Sullivan analyzes the PACS markets within the United States,
Latin America, and select Asian countries. By studying detailed insights into
emerging applications and identifying growth opportunities, your firm will have
the strategic knowledge to improve its competitive position.

Lack of Cost Justification Curbs Early Market Growth

Like many high-end imaging devices, PACS are expensive; an attribute not lost
on potential customers. However, unlike other costly hospital equipment,
PACS do not generate income, leaving distributors at a disadvantage during
product promotion.

Vendors are normally able to overcome pricing qualms by explaining that

costly imaging equipment will increase revenues, thus paying for itself and
producing a net gain for the user, states the study’s author. However,

convincing a potential PACS customer requires a great deal of justification

and demonstration of the savings available primarily through increased
efficiency and productivity.

Falling LCD Prices Spur Demand for Dedicated Display Workstations

Compared with conventional cathode ray tube (CRT) monitors, flat-panel
liquid crystal displays (LCDs) are more compact and require less electricity.

Although dedicated LCDs cost nearly twice as much as comparable CRT units,

they are considerably less expensive to operate and last almost five
times longer.

The total cost of ownership of the new LCD technology can actually be

lower than t

U.S. Computed Tomography Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:45 GMT

Technology Evolution Sparks New Growth for Aging Market

Computed tomography (CT) has made a place for itself in the healthcare field
by providing a non-invasive means of examining internal body structures and
diagnosing disease. Although the field was nearing maturation several years
ago, it has been significantly altered by evolving technology trends which have
revitalized the industry.

This Frost & Sullivan research provides a detailed analysis of the U.S.

computed tomography markets. By identifying emerging trends and delving
into the cardiac and electron beam tomography (EBT) segments, this study

supplies your company with valuable information about growth opportunities

in this flourishing industry.

Multi-Slice Scanners Revolutionize Field, Propel Sales

The multi-slice scanner has impressed end users by offering increases in the
number of slices and sectional thinness, thereby nearing true volumetric
scanning. Scan speed has also improved, resulting in a number of single-breath
applications that until recently could not be performed with CT scanners.

The introduction of multi-slice CT has been one of the most exciting
enhancements ever brought to the market,” says the study’s author. “The

technological innovations that have been made within the realm of CT over

the past three years are revolutionary and should be the primary drivers for
future industry growth.

Cardiac CT, EBT Units Create Lucrative Niche Markets

Cardiac CT and EBT represent an emerging niche within the traditional CT

market. Both sectors are expected to focus on cardiac centers within
hospitals, freestanding imaging centers, and new preventive screening centers.

It is expected that the cardiac and preventive screening markets will provide

additional momentum to revitalize the CT scanner market,” states the analyst.
“Although these segments will not represent potential as vast as the radiology
market, they will help to expand the installed base of CT s

Pan Asian Magnetic Resonance Imaging (MRI) Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:45 GMT

Regional Economies Challenge MRI Equipment Growth Potential

Magnetic resonance imaging is a non-invasive technology that utilizes magnetic
fields and radio waves, rather than radiation to generate internal images of the
body. Although this equipment has become a medical necessity around the
world, the number of installed units within Pan Asian countries is still
relatively low, offering industry participants an enormous potential consumer
base. However, financial uncertainty in the region has significantly weakened
local currencies and limited the purchasing power of end users.

This Frost & Sullivan study provides a comprehensive analysis of the Pan Asian
MRI equipment markets. By identifying emerging technology trends and
providing strategic recommendation for industry success, this research offers
firms a useful tool for maximizing profit margins.

Malaysia’s Vision 2020 Brings Imaging Applications to Medical Forefront

Malaysia’s government is in the midst of expanding and upgrading the
country’s public hospital facilities to accomplish its goal of providing adequate

healthcare to all citizens in accordance with its Vision 2020 economic

development plan. Consequently, the MRI equipment market is expected to

demonstrate strong growth as the demand for replacement systems increases

and new units are installed.

Vision 2020 involves a series of objectives formulated by the Malaysian

government to be achieved by the year 2020. Imaging applications were
identified as one of the priority improvement initiatives. Hence, budgets for
the next five years have already been allocated for this capital-intensive
equipment, states the analyst of this study.

Procedural Costs Hinder Hospital Equipment Investments

The high costs associated with MRI scans are a serious deterrent for patients,

especially in low-income groups, from undergoing these procedures. Most
patients prefer less expensive X-ray or computer-aided tomography (CT)
scans, resulting in a

U.S. and European Digital Radiography Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:45 GMT

High Deployment Costs Hinder New Technology Growth

General radiography utilizes the conventional film-screen method of passing
X-ray photons through the body to create images of internal structures.

However, digital radiography (DR) substitutes an electronic detector panel
and digital display system for the film-screen cassette. This revolutionary
technology reduces patients’ exposure to X-rays and offers the cost-savings
associated with digital formatting. Despite these advantages, high initial
start-up costs are slowing widespread adoption by healthcare facilities.

This Frost & Sullivan study provides a comprehensive evaluation of the U.S.

and European digital radiography markets. By examining industry challenges
and providing strategic recommendations, this research offers your firm the
inside information needed to develop an effective business plan.

Long-Term Savings Key to Attracting Cost-Conscious Consumers

General radiography is the largest cost contributor and one of the most

inefficient applications for radiology departments. The cost consciousness of
healthcare providers, coupled with digital radiographys ability to provide
greater savings, is expected to be a prime factor influencing the long-term
success of the industry.

In todays managed care environment, healthcare organizations continue to
look for ways to contain costs, improve operating efficiencies, and increase
patient satisfaction, states the study’s author. Digital radiography systems

have attributes that correspond nicely with the newfound needs of hospitals

brought on by managed healthcare.

Manufacturers Struggle to Meet Demand for Detector Plates

Although a few dedicated facilities that produce DR detector plates—the
most important system component—are finally operational, most are not
working at full production capacity. Manufacturers are struggling to make
detector plate production faster, more efficient, and less expensive.

Determining and implementing

U.S. Sleep Apnea Diagnostics and Therapeutics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:44 GMT

Untapped Patient Population Key to Industry Growth

Sleep apnea is as common a disease as adult diabetes. However, limited public

knowledge of this disorder and treatment options have left the vast majority

of sufferers undiagnosed. Considering the potential patient population, the
possibility for growth within this underserved market is tremendous. As there
is no cure for obstructive sleep apnea (OSA), the dependence on

therapeutic equipment will result in strong product demand by a more

cognizant populace.

This Frost & Sullivan study analyzes the state of the U.S. sleep apnea markets,
including in-depth evaluations of the diagnostic and therapeutic sectors. By
monitoring consumer trends and providing expert forecasts, this research
offers a comprehensive guide to this flourishing field.

Reimbursement Policies Impact Therapeutics Sales

Favorable healthcare insurance reimbursements for nasal and facial interfaces

continue to drive replacement sales within the therapeutics market. In
addition to normal product deterioration, private and government healthcare

providers have positively influence sales by offering reimbursements every

three months for the purchase of new nasal masks.

Despite the costs of frequent replacement, medical insurers are willing to pay
for these devices over a patient’s lifetime rather than risk the noncompliance
expenses related to life-threatening diseases such as congestive heart failure,
says the study’s author.

Educational Campaigns Instrumental for Increased Market Share

While the potential market for OSA therapeutic products is enormous,

participants must take a proactive role in helping patients and physicians
understand this disease and the available treatment options. Although

manufacturers have substantially smaller advertising budgets than pharmaceutical

companies, the impact of their campaigns are just as significant in the effort to
better inform the public, says the analyst.

Combined with the relative

U.S. Magnetic Resonance Imaging (MRI) Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:43 GMT

New High-Field Product Refinements Spur Market Growth

The patients experience with MRI procedures has been in need of
improvement for some time. Many individuals report anxiety and claustrophobia
as they become surrounded by a closed MRI tunnel. Manufacturers have

responded by introducing new designs which allow clinicians greater access to

the patient and reduce the subjects anxiety. Although open low- and mid-field
systems have been well received in the marketplace, the introduction of open
high-field equipment will spark new growth.

This Frost & Sullivan research examines markets for MRI systems according to
field strength (low-, mid-, and high-field) and system design (closed, and open
magnet). It tracks technology trends and assesses their impact on the
industry. By highlighting drivers and restraints and presenting expert revenue
forecasts, this study gives users a privileged view of this promising field.

Expansion of MRI Usage Presents New Opportunities

Diagnostic imaging devices are no longer the exclusive province of

radiologists, says the studys author. Many procedures, such as cardiac
catheterization, obstetric ultrasound, and echocardiography, are being
performed by other medical specialists.

The expansion of MRI applications to new fields should spur demand for these

systems. Participants capitalizing on this trend need to remain aware of

possibly alienating radiologists Manufacturers must develop innovative

strategies to sell their products in new markets without losing the goodwill of
their existing customers, says the author. This study examines changes in the

healthcare practice and recommends effective strategies to help your firm

overcome obstacles and optimize revenues.

Increased Number of Free-Standing Imaging Facilities Bolsters Customer Base

The transition from conventional hospital-based imaging to free-standing

imaging facilities will broaden the potential customer base for MRI systems

and provide additional opportunities fo

U.S. Emerging Prostate Cancer Therapeutics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:43 GMT

Prostate Cancer Cases to Rise as Baby Boomers Age

Next to skin cancer, prostate cancer is the second most common cancer for men within the United States. The risk of developing the disease significantly increases at age 50. By 2007, it is estimated that the male population in the U.S. over 50 years old will reach 41 million, substantially expanding the pool of prostate cancer patients and driving demand for reliable therapies with
limited side effects.

This Frost & Sullivan research provides an in-depth analysis of the U.S. emerging prostate therapeutics markets. By identifying market drivers and supplying strategic recommendations, this study offers your company a comprehensive guide to the future of this burgeoning field.

Devlopment of New Products with Fewer Adverse Patient Reactions Drives Market

Existing therapies for prostate cancer may be effective in managing the disease, but patient expectations with regards to toxicity and side effects are clearly not being satisfied. The urgent medical need for treatments that prolong survival with fewer side effects and improved quality of life is spurring research and development activity.

Promoting a product based on superior anti-tumor activity, with less toxicity and without compromising the quality of life of patients, is going to be key to
the success of any newly approved product, says the author of this research.

Widespread Media Coverage Increases Public Knowledge, Encourages Early Diagnoses

Prostate cancer traditionally was not a topic men felt comfortable discussing, and generally ignored the calls for early testing. However, as public knowledge and education continues to develop, the opportunity for diagnosis is becoming easier, increasing the number of patients requiring medical attention.

Prostate cancer has now taken on a visibility similar to breast cancer and has become a popular subject of discussion in the media. Screening for prostate cancer is becoming almost as easy and accessible as checkin

World X-Ray Mammography Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:42 GMT

Digital Mammography Is Poised for Full Market Impact

Early detection is crucial in treating breast cancer. By offering increased
contrast resolution, a wider dynamic range, a higher signal-to-noise ratio, and
real-time image enhancement capabilities, digital mammography will provide

important improvements in early detection rates and could ultimately help

save lives. Small-field digital systems have already shown strong sales since
their market debut, and full-field systems will follow suit when they enter the
marketplace in the coming years.

This Frost & Sullivan research analyzes the world markets for analog
mammography screening and stereotactic-interventional products as well
as small- and full-field digital systems. It presents in-depth technological

discussions and evaluates the growth potential in four distinct geographic

regions. With its detailed assessments of trends and its expert unit and
revenue forecasts, this research gives its users a clear view of the field.

Campaigning for Higher Reimbursements a Top Industry Priority

Most facilities that provide mammography services in North America and

Western Europe do so at a net loss, says the studys author. The majority of

facility administrators agree that mammography reimbursements are

inadequate given the expense of the equipment and required to perform
mammograms. Unless repayment for mammography services are increased,

facilities could be forced to restrict services or even close

their doors.

With less money to spend, customers are likely to delay or cancel purchases.

Forward-thinking industry participants and medical institutions must advocate

for higher reimbursement rates in order to sustain sales and provide effective

patient treatment. This study identifies emerging challenges and offers effective
strategic recommendations, enabling your company sustain revenues and
market share.

Consolidation Intensifies Competition to Attract New Customers

There has been significant mergers in

U.S. Diabetes Diagnostic Testing Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:42 GMT

Growth of At-Risk Population Sparks Demand for Diabetes Testing

The National Institute for Health estimated that the number of obese Americans has doubled in the last decade. Lack of exercise and poor diet, including foods that are high in fat, are likely to extend this trend for years to come. As physicians treat more and more overweight patients, they will order an increased number of laboratory tests to diagnose and monitor diabetes,
which correlates closely with obesity.

This Frost & Sullivan research analyzes the markets for diagnostic diabetes tests that are conducted in clinical labs, hospitals and physician office labs, including glycohemoglobin and lab-based glucose tests. By tracking trends and assessing their impact on the future of the industry, this study offers its users a privileged view of the marketplace.

Point-of-Care Technology Potential Challenge for Laboratory Tests

Point-of-care testing could eliminate laboratory testing in the long term, says the author of this research. The ability for nurses and other non-laboratory personnel to perform diabetes tests in a physicians office or at the hospital bedside could reduce the volume of laboratory-analyzed testing.

Point-of-care testing provides faster diagnoses, allowing physicians to discuss diet, exercise, and medication recommendations the same day.

Currently, point-of-care procedures have not significantly penetrated the market. But the analyst warns, If point-of-care testing becomes less expensive, easier to use, and more accurate, that could change. This study identifies market drivers and restraints, helping your company anticipate and overcome any obstacles that may lie ahead.

Laboratory Consolidation Decreases Customer Base for Test Manufacturers

Consolidation of clinical laboratories that began in the late 1980s is still ongoing, says the analyst. As long as this consolidation trend continues, the customer base for diabetes tests will shrink.

With fewer potential clients, reagent p

U.S. Osteoporosis Diagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:42 GMT

New Peripheral Technologies Drive Market Growth

As the baby boomer population ages, there will be an increased need to
accurately measure the degenerative loss of bone mass. The introduction of
peripheral bone densitometers, which measure bone density at the wrist, heel,
fingers, or forearm, will drive market growth, as non-hospital end users prefer
these faster, less expensive, portable devices to axial equipment, which
measures bone density at the hip and spine. Because peripheral technologies
are suited for non-hospital use, participants could discover new opportunities
in preventive care sectors.

This Frost & Sullivan research analyzes the markets for both axial and
peripheral densitometers, including subsegments for equipment with specific
scanning capabilities. It evaluates drivers and restraints, identifies areas with
growth potential, and provides expert forecasts. With such a comprehensive
guide to the industry, your company will be poised to optimize its resources
and enhance its bottom line.

Creating Awareness for New Products is a Top Priority

Technological innovations and improvements have surfaced that will expand

the markets offerings substantially, says the studys author. Nevertheless,
positioning these new products remains an obstacle for many manufacturers.

Without a solid promotional program, new devices often remain unknown to
healthcare institutions, and penetration is substantially diminished.

Manufacturers must educate not only hospitals and outpatient care facilities

about new technologies, but also the public about the importance of
osteoporosis screening. This research highlights emerging industry challenges,
enabling your firm to anticipate and overcome hurdles that may lie ahead.

Forging Alliances and Expanding Target Markets Should Be High Priorities

To simultaneously advocate the benefits of early screening and promote the

availability of drugs without side effects, alliances must be formed between
diagnostics manufacturers a

U.S. Stroke Therapies Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:41 GMT

Already a leading cause of death, stroke cases are expected to double during
the next half century. Consequently, the markets for stroke therapies offer

important opportunities for companies that can overcome research

challenges. Market participants must continue to research new classes of
drugs, combinations of agents, and alternate treatments in what may seem to
be a never-ending search for effective treatment.

This compelling Frost & Sullivan study analyzes the markets for stroke
therapies and examines current research activities for therapeutics. Following
an overview of the diseases risk factors, symptoms, tests, and treatments, this
report evaluates market drivers, restraints, and challenges. With its detailed
discussions of emerging products and its expert forecasts, this report offers
key insights into the future of a growing industry.

Increasing Public and Physician Awareness Key to Market Growth

There is currently a lack of knowledge regarding stroke symptoms and how

to react if someone develops these symptoms, writes the researchs author.

The development thrombolytic agents for stroke means that fast diagnosis and

treatment can stop artery blockage in the brain, sparing nerves and saving
related physical functions. Unfortunately, the public perception that stroke is
untreatable often prevents stroke victims from receiving prompt care.

Pharmaceutical companies also must devote resources to educating healthcare

providers as to identifying eligible patients and administering drugs within the
appropriate time frame. This report, which surveys recent medical studies and
assesses their implications for the marketplace, is an essential tool for
industry participants.

Continued Investments In Research and Development Crucial For Success

Many drugs that were thought to be great drug candidates in the early stage

have produced disappointing results in late clinical trial stages, says the
author. A glycine antagonist was promising in early research but

U.S. Asthma Therapeutics Market

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:40 GMT

New Product Classes Offer Significant Growth Opportunities

The emergence of leukotriene modifiers and combination therapies show

promise in a highly competitive market. Leukotriene modifiers are
maintenance therapy drugs and an alternative to the long-term use of
corticosteroids. Convenience is the primary advantage of combination
therapies, as these pills combine two or more asthma drugs into one dosage,
making treatment more efficient. Both product classes result in increased
compliance as patients realize the benefits of these orally-administered and
easy-to-use therapies.

This Frost &Sullivan study forecasts future revenues of the drug classes that
dominate the prescription asthma drug market: brochodilators, anti-inflammatories, leukotriene modifiers, and combined therapies, while also offering an
overview of new drug classes in development. This deliverable provides
market drivers and restraints for each drug segment, and recommends
strategies to formulate an efficient business plan.

Developing Brand Loyalty Essential for Success

It is important that drug manufacturers market their asthma therapies to all

healthcare groups that diagnose and treat asthma in an effort to build brand
loyalty. Asthma is treated by a number of different medical professionals,
including primary care physicians, respiratory specialists, and emergency room
doctors, all of whom use diverse treatments for this disease.

The primary care physician segment presents the largest opportunity to build

a successful and loyal following. Primary care providers account for nearly 56
percent of all prescriptions written for asthma medications, states the author
of this study. Implementing educational campaigns to promote brand loyalty
among all provider groups is a key opportunity to increase market share.

Market for Mild Asthmatics Poised for Expansion

An estimated 90 percent of patients suffering from severe persistent asthma

get treated with prescription drugs, while only five to eig

U.S. Three-Dimensional (3-D) Medical Imaging Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:40 GMT

Three-Dimensional Imaging Moves From The Drawing Board To The Clinic

The market for 3-D imaging technologies used in medical applications has

clearly passed from the research stage to product development and clinical

application. The implementation of new, PC-based technologies and an

increase in clinical applicability will drive impressive growth in this burgeoning

field. As awareness of 3-D technologies continues to expand over the forecast
period, revenues are expected to rise exponentially.

This Frost &Sullivan report analyzes the markets for 3-D, CT, MR, and angiography equipment and ultrasound-based technologies. It highlights key market
drivers and restraints, recommends effective strategies, and provides expert
forecasts. With such a privileged view of the marketplace, your company will
be poised to capitalize on a very promising field.

Meeting Reimbursement Challenges Will Define Market Leader

The falling level of medical reimbursements has emerged as the primary challenge facing healthcare technologies during the last decade, writes the
report s analyst. Imaging has been strongly affected by low reimbursement levels because of the high capital expenses associated with imaging technologies.

Three-dimensional imaging poses an even greater dilemma in terms of reimbursement, warns the analyst. Although prices for 3-D have generally
decreased, insurers still perceive the technology as having relatively low clinical utility. A CPT code does exist to cover some types of 3-D imaging, but it
still excludes a number of procedures. This report identifies key industry challenges and assesses their impact on the marketplace, helping your company
anticipate and overtake potential hurdles.

Shift to PC-Based Platforms Could Reduce Imaging Costs

The most significant technology trend is the shift of 3-D imaging workstations from UNIX to PC-based (NT) platforms, writes the analyst. While
UNIX systems provided the speed and computer power needed for the complex com

World Medical Diagnostic Ultrasound Imaging Equipment Market

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:40 GMT

Healthcare Reforms Encourage Strategic Alliances

Ultrasound imaging is a safe, non-invasive, non-ionizing procedure that makes it a routine treatment choice among physicians. However, continued cost-containment ressures from managed care organizations, such as Medicare, are
forcing ultrasound equipment manufacturers to minimize costs while still providing quality products. Companies can increase their chances for success by partnering with other participants to increase market share, save on research and development costs, and enter new application areas.

This informative Frost & Sullivan study analyzes the radiology, cardiology, obstetrics and gynecology, interventional, and other segments of the world
medical diagnostic ultrasound imaging equipment markets. By identifying prime market drivers, restraints, and challenges, Frost & Sullivan provides the detailed information you need to find success in this industry.

Under-Served Regions Spur Market Growth

Competition in this industry is extremely intense, especially in the U.S., western Europe, and Japan. Forward-thinking companies have begun to look outside these established markets and are turning their attention to developing markets in the Far East, Eastern Europe, and Latin America. The rapidly increasing demand for ultrasound equipment in these regions is expected to
drive growth over the forecast period.

These emerging markets are where the future growth of this industry is headed, states the author of this report. Establishing a global presence in these regions, backed by a good distribution network and customer service, is the recipe for achieving significant market penetration.

Refurbished Equipment Market Flourishing

In the past, the use of refurbished imaging equipment was seldom practiced. The improving quality of these systems over the years, however, means there is substantial growth opportunity for companies that can renovate used ultrasound imaging systems.

The refurbishing industry for imag

U.S. Magnetic Resonance Imaging (MRI) Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:39 GMT

MRI Pushes its Limits in Field Strength, Openness and Price Implementation

Challenge

Identification
High field strength is crucial for obtaining the best quality MRI image. More
and more, applications in the industry are calling for higher resolution images
that require higher field strengths. MRI systems with stronger imaging power
are now being purchased at a much higher rate than in the past. The advent of
the 3T systems, which are very high-field systems used in neurology and psychiatry,
characterizes the trend and need for highest field strength.

However, as imaging techniques improve, even lower field systems perform
with a quality level that would have been impossible only a few years ago. For
applications that can be performed with lower field strength, other key factors
such as openness and price become most important. The economical MRI systems
represent a fundamental approach to meeting customer demands.

Customers tend to purchase equipment that either has the highest field

strength or the lowest cost, instead of opting for a mid-range system. The

improvements in imaging and different field strengths are allowing the development

of new applications for either highest quality or lowest price. This, in
turn, is improving market penetration for MRI equipment, especially in the
clinical segment where both types of systems can find several applications.

Customer Satisfaction Crucial for Survival

Increasing scanning comfort increases the application penetration or utilization,

states the author of the report. For example, minimally invasive MRI
will not penetrate the market at its fullest potential if surgeons have to per-form

the surgery while squeezed in a tight place and wearing ear plugs to

tolerate the noise of the MRI system.

Patient comfort is a driving factor that has become the source of many technical

advances in the past few years. The success of the open MRI, which many
patients prefer, has proved customer satisfaction is becoming cruc

European In-Vitro Cancer Diagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:38 GMT

This report from Frost & Sullivan divides the in-vitro cancer diagnostics market into an in-depth analysis in each of the four segments - immunoassay, immuno-histochemistry, clinical chemistry and nucleic acid based. This report focuses specifically upon the markets in Germany, France, Italy, United Kingdom, Spain, Benelux, and Scandinavia. New technologies are emerging in the field of in-vitro cancer diagnostics. Tools that are used to diagnose, screen and monitor specific types of cancer may have a profound effect upon this industry. Nucleic acid base testing, based on polimerase chain reaction (PCR), and fluorescent in-situ hybridization (FISH) technologies are set to revolutionize the cancer diagnostic market by providing much of the revenue growth in the medium and long term. These novel techniques offer a higher level of specificity and sensitivity than traditional technologies, enabling earlier detection of cancer and enhanced follow-up testing. The launch of new chemosensitive assays, which establish whether or not patients are genetically compatible with cancer therapies, will create a new market in the field of in-vitro cancer diagnostic testing, states the author of the report.

The European in-vitro cancer diagnostics market has recently experienced declining revenues as a result of the consolidation of testing laboratories. This consolidation enhanced end-user purchasing power, leading to falling prices in the immunoassay and clinical chemistry markets, which deterred many new entrants from joining the market. Ten companies in this market now hold eighty-three percent of the market share. In light of this consolidation trend, small and medium-sized companies have been struggling to maintain the adequate level of research and development, spending what is necessary to continue to provide a broad range of testing parameters. Smaller firms are finding they must concentrate on niche marketing areas in order to avoid being forced out of the market altogether

Indian Computed Tomography and Magnetic Resonance Imaging Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:37 GMT

Because Indian doctors have a high degree of awareness of the latest treatment technologies, demand for the two medical imaging modalities covered in this report from Frost & Sullivan continues to rise. The report includes a detailed analysis of the market trends, major competitive factors, and regulatory and legal issues in the industry. The impact of governmental tariff changes is studied in detail, and the growing importance of service in a largely undifferentiated product market is discussed. Profiles of equipment manufacturers like Birla Elscint, Blue Star, Siemens, and Wipro are provided.

European Medical Diagnostic Ultrasound Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:28 GMT

The European markets for medical diagnostic ultrasound equipment are projected to see extensive growth throughout the forecast period. Along with forecasting future revenues and pricing trends for the total market, this report evaluates and analyzes growth opportunities in ten individual product segments within the European medical diagnostic ultrasound equipment market. The report also provides up-to-date discussions of market drivers and restraints, giving its users a comprehensive guide to help overcome market obstacles. The report monitors exciting industry trends, presents effective strategic recommendations, and includes profiles of key industry participants. From Frost & Sullivan.

Chinese Ultrasound Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:27 GMT

The Chinese markets for diagnostic ultrasound equipment have seen double-digit growth over the last few years. This report analyzes the Chinese markets for both black-and-white and color ultrasound equipment. With its examination of drivers and restraints and its revenue and unit forecasts, this report offers its users a detailed road map to the future of the industry. This study also provides extensive discussions of economic issues specific to China, evaluates the tactics of winning companies, and presents strategic recommendations. From Frost & Sullivan.

U.S. Sleep Disorders Diagnostic and Therapeutic Device Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:27 GMT

Sleep disorders has been a growing concern in the U.S., with an estimated 40 million Americans suffering from such afflictions. This report evaluates current states of the sleep disorder diagnostic and therapeutic device markets and forecasts future revenues, revenue growth, product pricing and unit sales information your company needs to thrive in the present marketplace. This report also identifies key challenges facing the industry and offers your company strategies necessary to overcome future market restraints. From Frost & Sullivan.

U.S. Clinical Laboratory Information System (CLIS) Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:25 GMT

As the healthcare industry evolves into fewer but larger institutions, bigger and more expensive laboratory systems will be required to meet the resultant computing needs. This report provides insight into customer buying patterns, perceptions of products, and system needs, helping companies identify the trends indicative of the industrys future. The report will help its users develop effective sales strategies and review their technology patterns. Profiles of key industry participants are also included. From Frost & Sullivan.

World Nuclear Medical Imaging Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:24 GMT

Abundant opportunities for growth provide participants and observers of the world nuclear medical imaging equipment markets with more reason for an optimistic outlook than ever before. This report covers the major issues, trends, challenges and opportunities in this market. It places particular emphasis on forecasts of the market segments of the future, including CD-SPECT, dual-head variable angle, and global positron emission tomography (PET) procedural volume. The report offers a true market focus that can help companies with business development plans, sales intensity, and other marketing and research and development challenges. From Frost & Sullivan.

Singaporean, Indonesian and Malaysian Ultrasound Diagnostic Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:24 GMT

This report segments ultrasound diagnostic equipment markets according to unit prices and also provides in-depth analyses for each geographic region. By evaluating the short- and long-term impact of the economic crisis on each product segment and by presenting expert forecasts, this report offers readers a detailed road map to the future of this industry. The report examines customer needs and highlights the differences in preferences between regions. It also traces technology trends, provides market share, and includes profiles of key industry participants. From Frost & Sullivan.

U.S. Aesthetic Laser Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:24 GMT

Lasers for aesthetic use have shown a great deal of innovation over the past three years. This report evaluates the current state of the U.S. aesthetic laser market and forecasts future revenues, product pricing, and unit sales. The report also identifies key challenges facing the industry and strategies to succeed against such obstacles. For each product segment reviewed, both market drivers and market restraints are assessed. The total market covered in this report includes the rapidly growing hair reduction laser markets, the evolving market for invasive skin resurfacing lasers, and the markets for vascular and pigmented lesion treatment. From Frost & Sullivan.

U.S. DNA/RNA Probe Diagnostic System Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:23 GMT

This Frost & Sullivan report forecasts opportunities for growth in the U.S. DNA/RNA probe diagnostic systems marketplace, identifies key industry issues and trends, and provides analysis of products and the competitive environment. Based on first-hand information gathered from nearly 100 interviews with laboratory end users, opinion leaders in the market, and many others, this report can help you pinpoint your strengths, weaknesses, opportunities and threats within the context of the market.

U.S. Clinical Laboratory Markets: End-User Study

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:23 GMT

As end users become increasingly interested in integrated clinical chemistry and immunoassay systems, manufacturers continuing to produce only stand-alone systems may stand to lose market share. By evaluating the existing market share, installed base of systems, purchasing patterns, and consumable usage, according to the size of the end-user facility, this Frost & Sullivan report offers readers key insights into trends and changing customer demands. This end-user survey examines the responses of 201 hospitals and reference laboratories regarding the use of specific clinical laboratory analyzers.

U.S. In Vitro Cancer Diagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:23 GMT

The market for in vitro cancer diagnostics and monitoring is projected to grow, driven by an aging U.S. population and an increasing number of former cancer patients requiring continual monitoring to rule out further recurrence of cancer. This Frost & Sullivan report gives its users the knowledge necessary to evaluate the threats and opportunities in the market and to formulate strategies for the future. Outlining R&D pipelines for major disease areas and providing specific strategies for success, this report equips its readers with the most up-to-date information available.

European Metabolic Disease Therapy Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:23 GMT

An aging population and behavioral lifestyle changes are supporting the increasing incidence of metabolic diseases across Europe. This Frost & Sullivan report examines ongoing developments across this vast and dynamic industry. To provide a thorough overview of the European market, the report covers four disparate segments: diabetes, including both insulin and oral hypoglyceamic agents; obesity; growth hormones; and erythropoietin. The report provides information on market size and growth, market share, revenue forecasts, pricing strategy and trend analysis, the competitive structure, and more.

U.S. Clinical Laboratory Information System Markets: End-User Study

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:22 GMT

This timely end-user survey of 151 hospitals, independent laboratories, and physicians office labs provides an in-depth demand-side perspective on the clincial laboratory information system (CLIS) markets. It provides valuable feedback on customer perceptions, opinions and values that determine purchasing patterns. The study analyzes the specific needs of laboratories of all sizes, helping your company target market opportunities and maximize gains.

European HIV/AIDS Diagnostics and Monitoring Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:22 GMT

This Frost & Sullivan report provides a detailed analysis of HIV testing throughout Western Europe. The reports analysis of the main sectors of the industry highlights the specific trends in each area in terms of revenue growth, pricing trends and market share analysis. It includes a forecast of expected market developments, and outlines the differences among countries and their attitudes towards HIV/AIDS testing and monitoring. It includes HIV prevalence rates for each European region covered, as well as profiles of key industry participants.

U.S. Home Diagnostics and Monitoring Device Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:21 GMT

This Frost & Sullivan report offers in-depth analysis of the U.S. markets for home temperature monitoring devices, blood-pressure monitoring devices, pregnancy and ovulation test kits, cholesterol monitoring devices, HIV diagnostics, blood-glucose monitoring products, and screening devices for drugs of abuse. It includes coverage of evolving technologies, emerging opportunities, analysis of market shares, distribution channels, and profiles of key industry participants.

European Biosensor Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:21 GMT

New technological advances and the high demand for biosensors give market contenders considerable leverage to increase their market share. This in-depth report from Frost & Sullivan identifies specific production challenges and gives you the information you need to stay on top of industry trends. It highlights competitive issues, offers strategies for moving ahead in the market, identifies key market segments that are projected to expand, reviews economic factors that will affect the market, and provides market forecasts.

U.S. Biosensor Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:21 GMT

Advances in technology and manufacturing are creating increasingly reliable and accurate biosensor-based devices. This Frost & Sullivan report analyzes the major markets in the medical biosensor industry: home diagnostics, point-of-care, and medical research. The study evaluates the competitive structure of each market and provides strategic recommendations. It also covers environmental, industrial, and other biosensor markets, and includes a presentation of drivers, restraints, and revenue forecasts. Key industry participants are profiled.

World Magnetic Resonance Imaging Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:19 GMT

The trend toward cost containment in the healthcare field has led to the development of two new technologies: short-bore magnets and open systems. This Frost & Sullivan report analyzes the major market segments in for the MRI industry, including standard and open MRI systems, as well as MRI magnets, coils, and contrast agents. It provides expert forecasts of revenues and growth rates in major world regions, as well as profiles of key industry participants.

U.S. Peptic Ulcer Therapeutics and Helicobacter pylori Diagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:19 GMT

Experts estimate that 25 million people in the United States suffer from peptic ulcer disease but that only 20 percent see a doctor and are diagnosed. These numbers must change if manufacturers and vendors of ulcer therapeutics and diagnostics products want to exploit the U.S. markets full potential. This Frost & Sullivan report offers an objective look at each peptic ulcer therapeutics product category and highlights crucial trends and competitive issues in the marketplace. It examines rapid microbiology tests and breath urea tests for detecting H. pylori, pinpointing where your company should focus its resources for expansion.

U.S. Diabetes Insulin Delivery System Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:18 GMT

As baby boomers enter their 40s and 50s, the population with Type 2 diabetes will increase, presenting great opportunity for the expansion of the insulin delivery systems industry. This Frost & Sullivan report provides in-depth analyses of the major product segments of the insulin delivery systems industry, including markets for insulin syringes, as well as jet injection, insertion aid, insulin pen, and insulin pump devices. It also examines market drivers and restraints and provides expert forecasts for each industry segment.

European Neurodiagnostic Product Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:18 GMT

A tough competitive environment and increasing demand for cost-effective care characterize the European neurodiagnostic product markets. This Frost & Sullivan reports market analyses and forecasts segment the industry by product type, so the information is applicable to companies offering products in only one area and to those diversifying into new product areas. Includes profiles of key industry participants.

European Diabetes Diagnostics and Equipment Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:16 GMT

This report from Frost & Sullivan tracks the causes behind the strong growth in recent years, and provides a detailed overview of the prevailing trends and competitive strategies in the industry. New products in development are discussed in the report, as are the demographics of the total European diabetes population now and through 2010. In addition, major equipment manufacturers like Gamidor, Pierce Chemical, Data Medical, and HemoCue are profiled.

European Immunodiagnostics Markets

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:16 GMT

The shift away from isotopic technologies in favor of their safer, less-expensive non-isotopic counterparts is reshaping this industry. This report from Frost & Sullivan s team of medical industry experts looks at the ramifications of this transition, and discusses what lies ahead for radioimmunoassay market participants. It also offers a glimpse into the promising future of the chemiluminescent segment. Profiles of top companies like Bayer, Hybritech, Ortho, and Dade-Behring are included.

Asian Markets for MRI and CT Equipment: Focus on Singapore, Indonesia, and Malaysia

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:15 GMT

Growth for these markets in China has approached $150 million a year and is projected to continue going strong at least into the next decade. This report from Frost & Sullivan offers a comprehensive account of the MRI and CT markets, including segmented coverage of high-, mid-, and low-field MRI, as well as contrast media. Used and new equipment sales are included, and profiles of companies like Hitachi, GE Medical Systems, Philips, and Toshiba are provided.

Asian Markets for Magnetic Resonance Imaging and Computed Tomography Equipment: Focusing on China

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:15 GMT

Developments in Medical Sensors- Opportunities for Biosensors in Medical Diagnosis and Drug Discovery/Therapeutics (Technical Insights)

press@researchandmarkets.com — Tue, 21 Nov 2006 15:41:05 GMT

This Frost & Sullivan research service titled Developments in Medical Sensors provides an overview of the industry with a complete analysis of the technology trends, key market drivers and restraints, and industry challenges In this study, Frost & Sullivan's expert analysts thoroughly examine the...

U.S. HIV Diagnostics and Monitoring Markets

press@researchandmarkets.com — Thu, 16 Nov 2006 14:41:46 GMT

The last decade witnessed tremendous growth in the HIV diagnostics and management markets. Relentless efforts by activists, healthcare workers and scientists have brought HIV disease management to the top of research funding activity in the United States. Although a few players have dominant shares in individual market segments, new diagnosis and treatment strategies may expand certain market niches that could tilt the balance toward smaller players. Projecting continued growth in this booming market, this report forecasts rev-enues, product pricing and unit sales. Key market drivers and industry challenges are identified and proactive solutions are suggested to help your company establish a winning market plan. This report is an indispensible guide that will help your company take advantage of the new opportunities in this market and stay ahead of the competition. From Frost & Sullivan.

Sector Snapshot: Indias In Vitro Diagnostic Testing Industry

press@researchandmarkets.com — Fri, 04 Aug 2006 15:43:38 GMT

This "Sector Snapshot” is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot covers the Indian in vitro diagnostics (IVD) market which is currently manufacturing and selling products locally. This snapshot also details the major international IVD companies in India, major trends in the Indian IVD sector, Indian laboratory reagents manufacturers and suppliers, and the issues and priorities for India.

The Top 100 In Vitro Diagnostics Manufacturing Companies in Europe

press@researchandmarkets.com — Sun, 31 Aug 2003 10:56:00 GMT

The global IVD market is worth an estimated EUR 19.5 billion, broken down as follows:

Sector [EUR, million]
Clinical Chemistry 5,271
Infectious Diseases 5,627
Rapid TestsCoagulationEndocrine TestingGlucose 4,209
Haematology 1,253
Blood Grouping/Typing
The largest IVD segments are

Worldwide In-Vitro Central Lab Diagnostic Testing, 2002-2007

press@researchandmarkets.com — Sat, 21 Dec 2002 15:14:00 GMT

In Vitro Sweden AB

press@researchandmarkets.com — Sat, 21 Dec 2002 13:56:00 GMT

Our company report database is updated both through companies own participation and BioSeeker Group’s research. Daily updates and work with Sweden’s biotech companies make these company reports the most up-to-date.

- Classification data
- Contact data
- Date of incorporation and organizational number
- Business description
- Owner information
- Management
- Board
- List of authorized signees of the company
- Summary Financials
- Income statement (up to 4 years history)
- Balance sheet (up to 4 years history)
- Financial keys (up to 4 years history)
- Earlier name of corporation

This corporate profile is automatically delivered with the very latest available information.